Not applicableUnknownNCT04216121
What this trial is testing
LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib
Who this might be right for
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
Universitaire Ziekenhuizen KU Leuven 39